CAP

Solera Launches Innovative Used Car Lending Solution - Solera Auto Finance

Retrieved on: 
Friday, March 11, 2022
Redcap, Industry, NADA, Dealership management system, National Automobile Dealers Association, LoJack, Workflow, LLC, Friction, Multimedia, DMS, Solera Holdings, CAP, Program, IDMS, Lists of companies, Car dealership, Solera

Solera Auto Finance is an integrated financing solution that will enable franchise and independent dealers to provide competitive-rate auto loans to the full spectrum of used car buyers.

Key Points: 
  • Solera Auto Finance is an integrated financing solution that will enable franchise and independent dealers to provide competitive-rate auto loans to the full spectrum of used car buyers.
  • Solera Auto Finance provides franchise and independent dealers access to a "captive-like" financing solution that rivals even the most prominent used car disrupters.
  • Solera Auto Finance offers multiple compelling advantages:
    Attracting new customers The used car market is more competitive than ever.
  • Providing a fast, simplified lending solution for buyers and dealers With Solera Auto Finance, car buyers can receive financing decisions in seconds.

Mindera Health™ Appoints Ted St. Martin as Chief Financial Officer

Retrieved on: 
Thursday, March 10, 2022
ISO, Biomarker, Dickinson, Ernst & Young, Psoriasis, PX, Company, CLIA, Machine learning, Purdue University, CFO, Dermatology, Becton, Ernst, Precision medicine, Adoption, GLOBE, Ted, Patient, DNA sequencing, San Diego State University, CA, Growth, CAP, Certification, CEO, Pharmaceutical industry, Ligand Pharmaceuticals

San Diego, CA, March 10, 2022 (GLOBE NEWSWIRE) -- Mindera Health, developers of the ground-breaking Dermal Intelligence platform that is the first realization of precision medicine in psoriasis, has appointed Ted St. Martin as its Chief Financial Officer (CFO), effective March 7, 2022.

Key Points: 
  • San Diego, CA, March 10, 2022 (GLOBE NEWSWIRE) -- Mindera Health, developers of the ground-breaking Dermal Intelligence platform that is the first realization of precision medicine in psoriasis, has appointed Ted St. Martin as its Chief Financial Officer (CFO), effective March 7, 2022.
  • Ted joins us at a time when we are well-positioned to accelerate our commercial launch strategies, said George Mahaffey, President and CEO.
  • Previously, Ted was Chief Financial Officer at Dart Neuroscience, where he built a successful finance organization supporting the companys growth into late-stage clinical trials.
  • Mindera Health is a CLIA and CAP certified laboratory and has received ISO 13485:2016 certification.

Sigyn Therapeutics Appoints Alexander S. Yevzlin, MD, FASN to Its Scientific Advisory Board

Retrieved on: 
Wednesday, March 9, 2022
FASN, Securities Act of 1933, SAN, Internal medicine, University, Company, Inflammation, Coronavirus Scientific Advisory Board (Turkey), U.S. Securities and Exchange Commission, Diagnosis, Annual report, Hepatic encephalopathy, MD, Securities Exchange Act of 1934, Infection, Society, Septic shock, Risk, GLOBE, Sepsis, Security (finance), 2021 Essex County Council election, Technology, Community-acquired pneumonia, OTC Markets Group, CA, Therapy, CAP, Death, Dartmouth College, Pharmaceutical industry, Nephrology, Medicine

Dr. Yevzlins considerable extracorporeal industry experience and insight is expected to contribute to the clinical advancement of Sigyn Therapy.

Key Points: 
  • Dr. Yevzlins considerable extracorporeal industry experience and insight is expected to contribute to the clinical advancement of Sigyn Therapy.
  • Sigyn Therapeutics is a medical technology company focused on the treatment of pathogen-associated conditions that precipitate sepsis, the leading cause of hospital deaths worldwide.
  • This information in this press release contains forward-looking statements of Sigyn Therapeutics, Inc. (Sigyn) that involve substantial risks and uncertainties.
  • All forward-looking statements contained in this report speak only as of the date on which they were made.

Renalytix Launches myIntelX, Providing National Physician Access to KidneyIntelX Testing Platform

Retrieved on: 
Wednesday, March 9, 2022
NASDAQ, ISO, Biomarker, Veterans Health Administration, Centers for Disease Control and Prevention, University, Kidney disease, Physician, Risk, SALT, Breast, Public health, FDA, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Mount Sinai Health System, Prognosis, Medicaid, CKD, MD, VHA, DKD, CDC, GLOBE, Food and Drug Administration, Doctor of Philosophy, Patient, Geography, Atrium Health, Technology, Wake Forest, University of Utah, Chronic kidney disease, CAP, Food, Insurance, LSE, Dialysis, Center, Pharmaceutical industry

The Renalytix myIntelX portal is being launched in conjunction with the launch of KidneyIntelX testing within Atrium Health, which previously announced a collaboration with Renalytix in May 2021.

Key Points: 
  • The Renalytix myIntelX portal is being launched in conjunction with the launch of KidneyIntelX testing within Atrium Health, which previously announced a collaboration with Renalytix in May 2021.
  • Virtual capability provided through our myIntelX portal is an important step towards expanding access nationally to the KidneyIntelX proprietary technology, said Tom McLain, President, Renalytix.
  • Providing a mechanism that facilitates patient identification, access and monitoring is the first step towards improving overall care.
  • Additional features to support provider and patient education and engagement will follow as part of providing the comprehensive, fully integrated KidneyIntelX platform.

Immunovia, Inc. Laboratory Receives Accreditation from College of American Pathologists - a major step in the nationwide US roll-out of IMMray™ PanCan-d

Retrieved on: 
Tuesday, March 8, 2022
Licensure, Patient, National Accreditation Program for Rectal Cancer, College of American Pathologists, College, Doctor of Philosophy, Federation, Pancreatic cancer, Accreditation, CAP, List of pathologists, Accreditation Committee of Cambodia, MD, Physician, Medicine

The College of American Pathologists congratulated Thomas C. King, MD, PhD, Medical Director of Immunovia, Inc. for the excellence of the services being provided and advised him of this national recognition.

Key Points: 
  • The College of American Pathologists congratulated Thomas C. King, MD, PhD, Medical Director of Immunovia, Inc. for the excellence of the services being provided and advised him of this national recognition.
  • The U.S. federal government recognizes the CAP Laboratory Accreditation Program, begun in the early 1960s, as being equal-to or more-stringent-than the government's own inspection program.
  • During the CAP accreditation process, designed to ensure the highest standard of care for all laboratory patients, inspectors examine the laboratory's records and quality control of procedures for the preceding two years.
  • CAP inspectors also examine laboratory staff qualifications, equipment, facilities, safety program and record, and overall management.

Immunovia, Inc. Laboratory Receives Accreditation from College of American Pathologists - a major step in the nationwide US roll-out of IMMray™ PanCan-d

Retrieved on: 
Tuesday, March 8, 2022
Licensure, Patient, National Accreditation Program for Rectal Cancer, College of American Pathologists, College, Doctor of Philosophy, Federation, Pancreatic cancer, Accreditation, CAP, List of pathologists, Accreditation Committee of Cambodia, MD, Physician, Medicine

The College of American Pathologists congratulated Thomas C. King, MD, PhD, Medical Director of Immunovia, Inc. for the excellence of the services being provided and advised him of this national recognition.

Key Points: 
  • The College of American Pathologists congratulated Thomas C. King, MD, PhD, Medical Director of Immunovia, Inc. for the excellence of the services being provided and advised him of this national recognition.
  • The U.S. federal government recognizes the CAP Laboratory Accreditation Program, begun in the early 1960s, as being equal-to or more-stringent-than the government's own inspection program.
  • During the CAP accreditation process, designed to ensure the highest standard of care for all laboratory patients, inspectors examine the laboratory's records and quality control of procedures for the preceding two years.
  • CAP inspectors also examine laboratory staff qualifications, equipment, facilities, safety program and record, and overall management.

The World's first real passive income NFT, Cool Ape Planet, is ready to set a new benchmark in the fast-growing NFT industry and Metaverse

Retrieved on: 
Tuesday, March 8, 2022
Ethereum, CMC, Forbes, NFT, Headgear, USD, Discord, Industry, Collection, Non-fungible token, CAP, Clothing, Cryptocurrency, Metaverse

According to a recent Forbes article, giant conglomerates have actively entered or are ready to enter the NFT industry, preparing for the future i.e.

Key Points: 
  • According to a recent Forbes article, giant conglomerates have actively entered or are ready to enter the NFT industry, preparing for the future i.e.
  • Tons of NFTs have been introduced in the market but a brand new innovative concept, Cool Ape Planet NFT, will set a new benchmark in the NFT industry and the Metaverse.
  • Cool Ape Planet is here to rock the NFT industry like never before.
  • All the holders of Cool Ape Planet NFTs will be rewarded 10 tokens for each NFT every day.

Singapore Court Orders Largest Block of Illegal Streaming Sites in Singapore

Retrieved on: 
Tuesday, March 1, 2022
Settlement, Industry, Virus, BBC Studios, Ecosystem, Microsoft Windows, APTS, Drama, AVIA, Advanced persistent threat, YouGov, Association, High Court of Singapore, CAP, Discovery, Inc., General manager, Order, Android, Collegiate summer baseball, Online gambling, Cryptocurrency, Video game, La Liga

Singapore, Mar 1, 2022 - (ACN Newswire) - The Asia Video Industry Association's Coalition Against Piracy (CAP) commends the Singapore High Court for granting an Order to block 30 illegal streaming sites and almost 150 associated domains responsible for the distribution of considerable quantities of illegally streamed content in Singapore.

Key Points: 
  • Singapore, Mar 1, 2022 - (ACN Newswire) - The Asia Video Industry Association's Coalition Against Piracy (CAP) commends the Singapore High Court for granting an Order to block 30 illegal streaming sites and almost 150 associated domains responsible for the distribution of considerable quantities of illegally streamed content in Singapore.
  • Under the Order Internet Service Providers must disable access to these illegal sites and their associated domains.
  • The Order is part of CAP's ongoing campaign in Singapore and around the region against illegal streaming sites.
  • "Illegal streaming sites are simply illegal," said CAP's General Manager, Matthew Cheetham.

AnPac Bio’s Bio-Chip Subsidiary, Changwei System Technology Co., Ltd., Receives Independent Valuation and Approval from the Board to Explore Strategic Alternatives

Retrieved on: 
Thursday, March 3, 2022
Risk, Gu Changwei, Motorola, Patient, Semiconductor Manufacturing International Corporation, RMB, Amkor Technology, IC, Frost, Ministry, Knowledge, CDA, CLIA, Board, Letter, IVD, Company, IP, CEO, CAP, Frost & Sullivan, Diabetes, R, Disclosure, Ministry of Finance (Malaysia), Micron Technology, GLOBE, Mobile phone

The appraisal was performed following the recent approval from the board of directors of AnPac Bio to explore strategic alternatives for Changwei, including a potential strategic investment, to maximize shareholder value for the Company.

Key Points: 
  • The appraisal was performed following the recent approval from the board of directors of AnPac Bio to explore strategic alternatives for Changwei, including a potential strategic investment, to maximize shareholder value for the Company.
  • Changwei was founded in 2011 and has since focused on thedesign, R&D, and testingof novel, specialty bio-integrated circuit (IC) chips for life science applications.
  • There can be no assurance that the strategic review process will result in any strategic alternative, or any assurance as to its outcome or timing.
  • AnPac Bio is a biotechnology company focused on early cancer screening and detection, with 150 issued patents as of September 30, 2021.

National Disease Research Interchange Receives College of American Pathologists Accreditation

Retrieved on: 
Thursday, March 3, 2022
Science, Other Science, Biotechnology, Research, Pharmaceutical, General Health, Health, Infectious Diseases, Marie Cassidy, Patient, National Accreditation Program for Rectal Cancer, NDRI, Research, Hospital, National, Public sector banks in India, College, Organization, Doctor of Philosophy, Biomedical Research, Annual report, Federation, OPOS, National Disease Research Interchange, Accreditation, Eye, CEO, CAP, Cell, Accreditation Committee of Cambodia, TSS, Tissue, Pathology, Property management, NDRI, the College of American Pathologists, NDRI, THE COLLEGE OF AMERICAN PATHOLOGISTS

The Accreditation Committee of the College of American Pathologists (CAP) awarded accreditation to the biorepository of the National Disease Research Interchange (NDRI) in Philadelphia, PA based on results of a recent on-site inspection as part of the CAPs Accreditation Programs.

Key Points: 
  • The Accreditation Committee of the College of American Pathologists (CAP) awarded accreditation to the biorepository of the National Disease Research Interchange (NDRI) in Philadelphia, PA based on results of a recent on-site inspection as part of the CAPs Accreditation Programs.
  • NDRI is proud to have earned CAP Accreditation, said Bill Leinweber, president and CEO of NDRI.
  • The National Disease Research Interchange (NDRI) is the nations leading source of human tissues, cells and organs for scientific research.
  • As the worlds largest organization of board-certified pathologists and leading provider of laboratory accreditation and proficiency testing programs, the College of American Pathologists (CAP) serves patients, pathologists, and the public by fostering and advocating excellence in the practice of pathology and laboratory medicine worldwide.